ACM Shanghai board approves H-share listing on HKEX Main Board, up to 7% of share capital

ACM Research, Inc.

Board of ACM Shanghai (subsidiary of ACMR) approved H-share offering and listing on HKEX Main Board.
Proposed issuance of H shares up to 7% of total share capital post-offering, with 15% over-allotment option.
Use of proceeds: product development, R&D, global expansion, working capital, and loan repayment.
Listing subject to shareholder approval and regulatory clearances from CSRC, SEHK, SFC.
Resolution validity period of 24 months from shareholder approval, extendable if approvals obtained.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.